source
- Bristol Myers reports patient death in autoimmune CAR-T trial and explains summer pauseBristol Myers Squibb disclosed that a participant in its autoimmune CAR-T cell therapy study has died. The company said the death occurred during the trial and is under investigation, with details…
- Star Therapeutics raises $200 million to build new drug pipeline after Vega and Electra winsStar Therapeutics announced it has secured $200 million in financing. The capital will be used to develop its own pipeline of medicines, aiming to replicate the success of its earlier Vega and Ele…